Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2012
12/06/2012WO2012165314A1 Amide compound
12/06/2012WO2012164286A1 Novel ticagrelor co - crystal
12/06/2012WO2012164118A1 Bioactive polyphenolic compounds containing sulphur or selenium and uses thereof
12/06/2012WO2012163938A1 Fe(iii) 2,4-dioxo-1-carbonyl complexes for treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
12/06/2012US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences
12/06/2012US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators
12/06/2012US20120309747 Protein kinase inhibitors
12/06/2012US20120309710 Compound sea cucumber preparation and manufacturing method thereof
12/06/2012US20120308658 Methods and compositions to treat hemorrhagic conditions of the brain
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308641 Compositions and Methods for Enhancing Coagulation Factor VIII Function
12/06/2012US20120308639 Mesocellular Oxide Foams as Hemostatic Compositions and Methods of Use
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308581 Compositions and methods for detecting tlr3
12/06/2012US20120308571 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
12/06/2012US20120308559 Method of treating hemolytic disease
12/06/2012US20120308552 Hemostatic bio-material composition and method
12/06/2012US20120308545 Crystallized Oxalate Decarboxylase and Methods of Use
12/06/2012US20120308540 Modified factor IX polypeptides and uses thereof
12/06/2012US20120308525 Nutritional compositions including a high protein component and exogenous nucleotides
12/06/2012US20120308522 Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia
12/06/2012US20120308509 Method and Composition for In Situ Formation of an Artificial Blockage to Control Blood Loss
12/06/2012CA2837654A1 Methods and uses for ex vivo tissue culture systems
12/06/2012CA2836394A1 Novel ticagrelor co - crystal
12/06/2012CA2836202A1 Imidazopyridine compounds
12/05/2012EP2528895A2 Trypsin-like serine protease inhibitors, and their preparation and use
12/05/2012CN202568931U Novel compound capsule containing ferrous fumarate and folic acid
12/05/2012CN102812028A Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
12/05/2012CN102807619A Compound containing immunoglobulin Fc segment and granulocyte macrophage-colony stimulating factor and pharmaceutical compositions of compound
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102807605A Nalpha-(1,3-dioxo-4,4,5,5-tetramethylimidazoline-2-phenyl-4'-oxyacetyl)-Nomega-fatty acyl-Lys-Arg-Gly-Asp-Phe and preparation method and application thereof
12/05/2012CN102807604A N alpha-(1,3-dioxy-4,4,5,5-tetramethyl imidazoline-2-phenyl-4'-oxo acetyl)-N omega-fatty acyl-Lys-Arg-Gly-Asp-Val and preparation method and application thereof
12/05/2012CN102807600A Amino acid modified spinacin derivative and preparation method and application thereof
12/05/2012CN102807557A 3H-1,2-dithio-cyclopentene-3-thioketone compound and application thereof
12/05/2012CN102805859A Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
12/05/2012CN102805786A Preparation method of iridaceae eleutherine herb plant american eleutherine rhizome extract, and preparation thereof
12/05/2012CN102805769A Emergency medicine for treating nasal hemorrhage
12/05/2012CN102805764A Novel process for extracting lotus alkaloid by microwave-assisted solvent method
12/05/2012CN102805750A Composition of aescine derivative and salt thereof, preparation method and medical uses thereof
12/05/2012CN102805749A Dispersible tablet comprising clopidogrel and aspirin
12/05/2012CN102805732A Tanshinone IIA lipid microsphere preparation and preparation method thereof
12/05/2012CN102258758B High-content liquid gingerols and preparation method thereof
12/05/2012CN102258535B Method for preparing veterinary compound iron dextran injection and influence of veterinary compound iron dextran injection on growth of mice
12/05/2012CN102078603B Medicine with action of treating cardiovascular and cerebrovascular diseases
12/05/2012CN102028939B Medicine with hirudin-containing active ingredient
12/05/2012CN102028938B Medicament having effects of activating blood and dissolving stasis
12/05/2012CN101934044B Novel application of ginseng, tuckahoe and atractylodes preparation
12/05/2012CN101810768B Antithrombotic Chinese medicinal powder and preparation method thereof
12/05/2012CN101654427B Anticoagulant compound, composition and application thereof
12/05/2012CN101591344B Antithrombotic compound as well as preparation method and application thereof
12/05/2012CN101559059B Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof
12/05/2012CN101444499B Compound and new usage of composition thereof
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8324148 Delivering to the subject a compound comprising a nuclear localization sequence of NF-kB such that nuclear importation of NF-kB is inhibited
12/04/2012CA2590204C Amide compounds and thrombopoietin receptor activators
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2463879C Glycoprotein compositions
11/2012
11/29/2012WO2012162627A1 Treatment of angiogenic- or vascular-associated diseases
11/29/2012WO2012162611A1 Simukunin
11/29/2012WO2012161559A2 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012102937A3 Benz imidazole compounds that expand hematopoietic stem cells
11/29/2012US20120302640 Oral formulations
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302614 Method for improving cerebral circulation or treating a cerebral blood flow disorder
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302579 Cancer treatment method
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302536 Use of DHEA Derivatives for Enhancing Physical Performance
11/29/2012US20120302503 PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120301562 Composition for improving blood circulation, containing extract of lindera obtusiloba as active ingredient
11/29/2012US20120301510 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301458 Cyclopropyl modulators of p2y12 receptor
11/29/2012US20120301453 Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/28/2012EP2527340A1 Piperazine compound having a pgds inhibitory effect
11/28/2012EP2527336A1 Deuterated analogues of cilostazol
11/28/2012EP2527329A1 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/28/2012EP2526962A1 Therapeutic application of Kazal-type serine protease inhibitors
11/28/2012EP2526955A1 Lymphatic vessel stabilizer
11/28/2012EP2525779A2 Liquid formulations for long-acting erythropoietin conjugate
11/28/2012CN102803226A Cycloalkyl-substituted imidazole derivative
11/28/2012CN102803214A New compounds, pharmaceutical composition and methods relating thereto
11/28/2012CN102803199A Novel acetylsalicylic acid salts
11/28/2012CN102802686A Bone marrow extracellular matrix extract and therapeutic use thereof
11/28/2012CN102802659A Use of LCAT for treating anemia and red blood cell dysfunction
11/28/2012CN102802618A Therapeutic Combinations Of Nicotinic Acid And Meldonium
11/28/2012CN102802608A Dosage forms of apixaban
11/28/2012CN102796702A Preparation method for simultaneously culturing stromal stem cells and endothelial progenitor cells from marrow at one time and application of stromal stem cells and endothelial progenitor cells
11/28/2012CN102796201A Erythropoietin mimetic peptide (EMP)-human serum albumin (HSA) fusion protein and preparation method thereof
11/28/2012CN102796197A Human serum albumin-granulocyte colony stimulating factor (HAS-GCSF) mutant and preparation method thereof
11/28/2012CN102796168A Compounds with thrombolytic activity and preparation method and application thereof
11/28/2012CN102796167A (S)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-formyl-L-prolyl-L-alanyl-L-amino acid, and preparation method and application thereof
11/28/2012CN102796166A Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof
11/28/2012CN102796098A (1S, 3S)-1-1, 3-benzodioxole-1, 2, 3, 4-tetrahydrophthalic anhydride-beta-carboline-3-formyl-amino acid methyl ester, and preparation method and application thereof
11/28/2012CN102796093A Thiomorpholine-containing pyrrole derivatives and their preparation method and use
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 671